Las acciones de Pyxis Tankers Inc cotizan y se negocian en la bolsa de valores NASDAQ. ¿Cuál es el símbolo bursátil de Pyxis Tankers Inc? El símbolo bursátil de Pyxis Tankers Inc es “PXS”.

Pyxis Oncology (PYXS) announced significant progress in its clinical program for PYX-201, a first-in-concept antibody-drug conjugate, ADC, that uniquely targets Extradomain-B Fibronectin, a non ...

BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced ...

This Pyxis Oncology sponsored trial is investigating the novel extracellular targeting ADC PYX-201 in combination with pembrolizumab in multiple indications including but not limited to ...

Pyxis Oncology announces Phase 1/2 trials for PYX-201, combining it with KEYTRUDA® to treat advanced solid tumors. Pyxis Oncology, Inc. has announced the initiation of two significant clinical ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeuti BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE ...

The completion of the $3.0 million common share repurchase program demonstrates Pyxis Tankers' commitment to returning value to shareholders and potentially enhancing share price. Redemption of ...

Maroussi, Greece – January 30, 2025 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (“we”, “our”, “us”, the “Company” or “Pyxis Tankers”), an ...

Clásico 3.8834 3.8927 3.9064 3.9157 3.9294 3.9387 3.9524 Fibonacci 3.8927 3.9015 3.9069 3.9157 3.9245 3.9299 3.9387 Camarilla 3.9137 3.9158 3.9179 3.9157 3.9221 3.9242 3.9263 Woodies 3.8856 3. ...

Greetings and welcome to the user manual for your newly implemented system Pyxis Es User Manual. This manual is specifically designed to help you navigate the features and functions of your product ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...